New York Robotics Expert Visits Israel
NEW YORK, NY--(Marketwired - Nov 19, 2013) - David B. Samadi, MD, Chairman of Urology, Chief of Robotic Surgery at Lenox Hill Hospital, has returned from a recent prostate cancer mission to Israel. During this trip, Dr. Samadi visited Holon's Wolfson Medical Center to meet with other urologists and lecture on his custom Samadi Modified Advanced Robotic Technique (SMART) Surgery. He also offered private counsel to patients recently diagnosed with prostate cancer.
Dr. Samadi, considered one of the leading robotic prostate cancer surgeons in New York and internationally, is a board certified urologist and oncologist who has performed more than 5,200 successful robotic prostate surgeries. He frequently travels to Israel to educate urologists and physicians about prostate cancer diagnosis and treatment.
"Each year, I perform robotic surgery on about 100 Israeli men who come to New York seeking the best possible care -- and that's exactly what we provide," said Dr. Samadi.
Robotic surgery is gaining momentum around the world, yet even hospitals that can afford the $2 million price tag of a robotic system face a steep learning curve; one that requires surgeons to draw first on traditional surgical experience, then many hours of time behind the robotic controls. Even then, surgeons must perform several years' worth of procedures to reach Dr. Samadi's caseload and caliber of results.
"The surgeon performs the surgery, not the robot. That is my mantra. In order to offer patients around the world the best opportunities for prostate cancer cure, I am committed to helping surgeons gain substantial experience with and without the robot," said Dr. Samadi, noting, "this takes time."
Dr. Samadi's international lectures include focusing on the nuances of SMART Surgery, including his large and small customizations to the prostate removal procedure. He explains how, unlike other surgeons, he removes the walnut-sized prostate while preserving the delicate nerve bundles that surround it. By allowing this "skin" of nerves to remain intact, Dr. Samadi is able to preserve sexual potency and urinary control in the majority of his patients. For most, these quality of life metrics are tantamount to a prostate cancer cure.
"Most of my patients are out of surgery in about an hour, catheter-free in one week, and cancer-free for good," asserted Dr. Samadi.
Dr. Samadi's SMART Surgery for localized prostate cancer yields a cure rate of 97 percent. With proper adherence to postoperative care, patients rarely need follow-up treatment. For the vast majority of Dr. Samadi's patients, cancer-free living includes sexual potency and urinary control.
Back to Press Releases
Share on Facebook